Zhiyue Tom Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhiyue Tom Hu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bin Chen
Michigan State University
1 shared publication - Haiyan Huang
Department of Statistics , University of California Berkeley, Berkeley, CA 94720
1 shared publication Ilan Adler
UC Berkeley
1 shared publication- Ruoqiao Chen
Department of Pharmacology and Toxicology Michigan State University East Lansing Michigan USA
1 shared publication - Shan-Ju Yeh
School of Medicine, National Tsing Hua University, Hsinchu, Taiwan
1 shared publication - Tianyi Lin
Department of Industrial Engineering and Operations Research, Columbia University, New York, New York 10027
1 shared publication
Latest Publications
- Open Access
- 1 May 2025
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (3)
Large-scale information retrieval and correction of noisy pharmacogenomic datasets through residual thresholded deep matrix factorization
Pharmacogenomics studies are attracting an increasing amount of interest from researchers in precision medicine. The advances in high-throughput experiments and multiplexed approaches allow the large-scale quantification of drug sensitivities in molecularly characterized cancer cell lines (CCLs), resulting in a number of open drug sensitivity datasets for drug biomarker discovery. However, a significant inconsistency in drug sensitivity values among these datasets has been noted. Such inconsistency indicates the presence of substantial noise, subsequently hindering downstream analyses. To address the noise in drug sensitivity data, we introduce a robust and scalable deep learning framework, Residual Thresholded Deep Matrix Factorization (RT-DMF). This method takes a single drug sensitivity data matrix as its sole input and outputs a corrected and imputed matrix. Deep matrix factorization (DMF) excels at uncovering subtle patterns, due to its minimal reliance on data structure assumptions. This attribute significantly boosts DMF’s ability to identify complex hidden patterns among nuisance effects in the data, thereby facilitating the detection of signals that are therapeutically relevant. Furthermore, RT-DMF incorporates an iterative residual thresholding procedure, which plays a crucial role in retaining signals more likely to hold therapeutic importance. Validation using simulated datasets and real pharmacogenomics datasets demonstrates the effectiveness of our approach in correcting noise and imputing missing data in drug sensitivity datasets (open-source package available at https://github.com/tomwhoooo/rtdmf).
- 1 May 2025
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (3)
Open AccessLarge-scale information retrieval and correction of noisy pharmacogenomic datasets through residual thresholded deep matrix factorization
Pharmacogenomics studies are attracting an increasing amount of interest from researchers in precision medicine. The advances in high-throughput experiments and multiplexed approaches allow the large-scale quantification of drug sensitivities in molecularly characterized cancer cell lines (CCLs), resulting in a number of open drug sensitivity datasets for drug biomarker discovery. However, a significant inconsistency in drug sensitivity values among these datasets has been noted. Such inconsistency indicates the presence of substantial noise, subsequently hindering downstream analyses. To address the noise in drug sensitivity data, we introduce a robust and scalable deep learning framework, Residual Thresholded Deep Matrix Factorization (RT-DMF). This method takes a single drug sensitivity data matrix as its sole input and outputs a corrected and imputed matrix. Deep matrix factorization (DMF) excels at uncovering subtle patterns, due to its minimal reliance on data structure assumptions. This attribute significantly boosts DMF’s ability to identify complex hidden patterns among nuisance effects in the data, thereby facilitating the detection of signals that are therapeutically relevant. Furthermore, RT-DMF incorporates an iterative residual thresholding procedure, which plays a crucial role in retaining signals more likely to hold therapeutic importance. Validation using simulated datasets and real pharmacogenomics datasets demonstrates the effectiveness of our approach in correcting noise and imputing missing data in drug sensitivity datasets (open-source package available at https://github.com/tomwhoooo/rtdmf).
- Open Access
- 14 December 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 4828-4835
New Proximal Newton-Type Methods for Convex Optimization
In this paper, we propose new proximal Newton-type methods for convex optimization problems in composite form. The applications include model predictive control (MPC) and embedded MPC. Our new methods are computationally attractive since they do not require evaluating the Hessian at each iteration while keeping fast convergence rate. More specifically, we prove the global convergence is guaranteed and the superlinear convergence is achieved in the vicinity of an optimal solution. We also develop several practical variants by incorporating quasi-Newton and inexact subproblem solving schemes and provide theoretical guarantee for them under certain conditions. Experimental results on real-world datasets demonstrate the effectiveness and efficiency of new methods.
- 14 December 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 4828-4835
Open AccessNew Proximal Newton-Type Methods for Convex Optimization
In this paper, we propose new proximal Newton-type methods for convex optimization problems in composite form. The applications include model predictive control (MPC) and embedded MPC. Our new methods are computationally attractive since they do not require evaluating the Hessian at each iteration while keeping fast convergence rate. More specifically, we prove the global convergence is guaranteed and the superlinear convergence is achieved in the vicinity of an optimal solution. We also develop several practical variants by incorporating quasi-Newton and inexact subproblem solving schemes and provide theoretical guarantee for them under certain conditions. Experimental results on real-world datasets demonstrate the effectiveness and efficiency of new methods.